Endocavitary Radiofrequency Treatment in Patients Who Present With Chronic Pelvic Pain Compared to Usual Drug Therapy
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pelvic Pain
- Sponsor
- Universidad Rey Juan Carlos
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- NIH-CPSI questionnaire
- Last Updated
- 9 years ago
Overview
Brief Summary
- Treatment at pelvic floor with hyperactivity with hyperthermy electrode MJS
- MJS electrode is effective for transvaginal treatment at pelvic pain patients
- Hyperthermy treatment with MJS electrode is more effective to usual drugs treatment
Detailed Description
This study analyzed the evolution of chronic pelvic pain, defined by the different map of myofascial trigger points assets presents the patient with medical treatment compared to treatment with radiofrequency endocavitary electrode MJS. The initial evaluator analyzed by the NIH-CPSI Scale questionnaire and symptoms of chronic pelvic pain Stanford Protocol for female or male quality of life of the patient before the doctor or radio frequency and a month since treatment. the patient to the Principal Investigator, specialist physiotherapist, who appreciates tenderness the presence of a taut band with a map of pain in endopelvic and exopelvic muscles, determining the activation of myofascial trigger points in each is derived. The Principal Investigator proceeds to address each active myofascial trigger points with the MJS electrode four 20-minute sessions twice a week. The MJS has a curved end pressure which favors the compression point plus the location and accurate approach Radiofrequency pathological point as outstanding feature. The high specificity of myofascial treatment offered by the MJS electrode involves no danger, besides having the computer screen conductivity meter and a temperature sensor on the head to control both parameters in real time during the treatment session
Investigators
Marta Jerez Sainz
Director, coordinator of Pelvic floor department, Principal Investigator, Clinical Professor
Universidad Rey Juan Carlos
Eligibility Criteria
Inclusion Criteria
- •Women with chronic pelvic pain
Exclusion Criteria
- •chronic pelvic pain or neurological degenerative etiology
- •Presence of pathology or infectious processes genitourinary level
- •possibility of pregnancy or lactating.
- •Lack of informed consent, mental disorders, dementia, dependent people who need tutor.
Outcomes
Primary Outcomes
NIH-CPSI questionnaire
Time Frame: four weeks
questions for pelvic pain evaluation
Secondary Outcomes
- pain measure questionnaire(four weeks)